Previous studies have reported the utility of ADH‐1 in the inhibition of tumor establishment and growth in a range of pre‐clinical mouse models including pancreatic cancer, lung cancer and MM.34, 51, 52. Here, ADH1A is linked to pancreatic neoplasm.